Retina specialists are shifting from povidone iodine to chlorhexidine to prevent infections after eye injections. A new study says either approach is effective. Medscape Medical News
Tag: News
How Luxury Medicine Redefines Value and Patient Trust
Luxury-market tactics can help any specialty elevate perceived value, patient experience, and loyalty, says a healthcare luxury specialist. Medscape Medical News
Long-Term Control of NMOSD With Ravulizumab
For neuromyelitis optica spectrum disorder, long-term follow-up with a second-generation complement inhibitor shows an unprecedented level of disease control at 3 years. Medscape Medical News
Mutation-Agnostic Gene Therapy May Restore Vision in RP
The MCO-010 vector uses surviving cells in the retina to produce a photosensitive protein that may help patients regain some vision despite a loss of typical photoreceptors. Medscape Medical News
Ophthalmologists Often First to Spot Ocular Syphilis
Ocular syphilis is re-emerging in Europe and is often first detected by ophthalmologists, with acute placoid chorioretinitis being a common manifestation. Medscape News UK
Gene Therapy Shows Signal for Improving Retinal Function
Patients with potentially blinding retinitis pigmentosa recover retinal sensitivity 3 years after receiving a gene therapy targeting the causal mutation. Medscape Medical News
Aflibercept 8 mg Shows Gains in Previously Untreated AMD
Patients with age-related macular degeneration who are new to treatment experience gains in vision and anatomical markers 6 months after starting high-dose aflibercept, a study shows. Medscape Medical News
Study Supports Earlier Start for Geographic Atrophy Drug
Patients who start on pegcetacoplan for geographic atrophy at the outset of a 4-year study retain almost three times more macular tissue than those who wait to begin treatment. Medscape Medical News
AREDS Vitamins Show No Effect in Geographic Atrophy
An analysis of pivotal phase 3 trials shows supplements to arrest age-related macular degeneration have no effect on geographic atrophy. Medscape Medical News
Eye Surgery Follow-Ups: Does a Day Make a Difference?
Follow-up visits on the day of surgery may offer patients greater flexibility without sacrificing safety, a study shows. Medscape Medical News
Hypoglycemia Tied to Risk for Diabetic Retinopathy
Low blood glucose is linked to worsening eye disease in a new study. Medscape Medical News
Poll: Are You Practicing Medicine Abroad? Would You Like To?
Medscape’s editors are investigating what is needed to practice medicine in various countries around the world, and we want to hear from you! Medscape Reader Polls
US FDA Declines to Approve Outlook Therapeutics’ Eye Disease Drug, Shares Plummet
Outlook Therapeutics said on Thursday the U.S. health regulator has again declined to approve its experimental eye drug, citing a lack of substantial evidence of… Reuters Health Information
Diabetic Macular Edema: Second-Gen Anti-VEGFs Lead the Way
Medscape Medical News
Pill That Slows Aging? Meds May Boost Health Span
Metformin, rapamycin, and senolytics show multifaceted effects on aging biology that could transform how clinicians approach chronic disease prevention. Medscape Medical News
AMD Light Therapy Restores Vision Gains Post-Treatment Pause
A tabletop light therapy device led to vision improvements over 4.5 years and a long pause between treatments in people with dry age-related macular degeneration. Medscape Medical News
Simple, Noninvasive Eye Tracking May Flag Cognitive Decline
Naturalistic gaze patterns appear to be a simple, noninvasive, and reliable indicator of cognitive decline, new research suggests. Medscape Medical News
New Anti-VEGF Agents Extend Dosing Intervals in Wet AMD
New anti-VEGF agents for wet age-related macular degeneration can extend injection intervals to 3-5 months but may increase inflammation risk, prompting calls for tailored treatment plans. Medscape Medical News
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News